Metastatic renal cell carcinoma disease response in the era of immune checkpoint inhibitor-based combinations.

ABSTRACT:

SUBMITTER: Ostrowski M 

PROVIDER: S-EPMC12170065 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature